Published on IRCCS materno infantile Burlo Garofolo (https://www.burlo.trieste.it)

Home > Printer-friendly > State of the art of the therapeutic perspective of sorafenib against hematological malignancies.

State of the art of the therapeutic perspective of sorafenib against hematological malignancies. [1]

TitoloState of the art of the therapeutic perspective of sorafenib against hematological malignancies.
Publication TypeJournal Article
AuthorsZauli, G [2], Voltan, R [3], Tisato, V [4], Secchiero, P [5]
PubMed ID22934770 [6]

Source URL: https://www.burlo.trieste.it/ricerca/pubblicazioni/state-art-therapeutic-perspective-sorafenib-against-hematological-malignancies#comment-0

Collegamenti
[1] https://www.burlo.trieste.it/ricerca/pubblicazioni/state-art-therapeutic-perspective-sorafenib-against-hematological-malignancies
[2] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=1001
[3] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=2250
[4] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=2251
[5] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=1332
[6] http://www.ncbi.nlm.nih.gov/pubmed/22934770?dopt=Abstract